Algo version: 0.98b
IPA is listed at the NASDAQ Exchange
IPA [IPA]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is IPA stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Wednesday 29th of October 2014, ImmunoPrecise Antibodies had a stock price of $0.315. If you invested back then, your return now would be a profit of $0.0709 per share or 22.50%

No, the average daily trading liquidity for ImmunoPrecise Antibodies is $215 686 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

ImmunoPrecise Antibodies has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for ImmunoPrecise Antibodies to be medium [0.7 out of 1]